All news articles for March 20, 2015

Sanofi signs CRO Evotec to €250m, five-year research partnership

Sanofi signs CRO Evotec to €250m, five-year research partnership

By Zachary Brennan

The strategic partnership comes with Sanofi providing €250m to Evotec, including €40m upfront, as part of efforts to discover new drug candidates, including in the area of oncology, and specifically at Sanofi’s R&D site in Toulouse, France.

Follow us

Products

View more

Webinars